Financial Snapshot: Analyzing Alx Oncology Holdings Inc (ALXO)’s Key Ratio Metrics

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

The closing price of Alx Oncology Holdings Inc (NASDAQ: ALXO) was $1.58 for the day, down -8.14% from the previous closing price of $1.72. In other words, the price has decreased by -$8.14 from its previous closing price. On the day, 1.26 million shares were traded. ALXO stock price reached its highest trading level at $1.71 during the session, while it also had its lowest trading level at $1.56.

Ratios:

Our analysis of ALXO’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.82 and its Current Ratio is at 4.82. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on March 08, 2024, Downgraded its rating to Hold and sets its target price to $14 from $10 previously.

On December 08, 2023, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $18.

Jefferies Downgraded its Buy to Hold on December 22, 2021, whereas the target price for the stock was revised from $65 to $25.

Insider Transactions:

Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 02 ’24 when Hemrajani Rekha bought 30,000 shares for $1.55 per share. The transaction valued at 46,404 led to the insider holds 33,000 shares of the business.

Pinto Shelly sold 564 shares of ALXO for $1,455 on Aug 14 ’24. The SVP, FINANCE AND CAO now owns 91,549 shares after completing the transaction at $2.58 per share. On Aug 14 ’24, another insider, Randolph Sophia, who serves as the CHIEF MEDICAL OFFICER of the company, sold 1,365 shares for $2.58 each. As a result, the insider received 3,522 and left with 325,711 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 83334104 and an Enterprise Value of -40497860.

Stock Price History:

Over the past 52 weeks, ALXO has reached a high of $17.83, while it has fallen to a 52-week low of $1.19. The 50-Day Moving Average of the stock is 4.80%, while the 200-Day Moving Average is calculated to be -77.24%.

Shares Statistics:

ALXO traded an average of 730.96K shares per day over the past three months and 1022780 shares per day over the past ten days. A total of 52.74M shares are outstanding, with a floating share count of 34.30M. Insiders hold about 34.96% of the company’s shares, while institutions hold 58.48% stake in the company. Shares short for ALXO as of 1731628800 were 7225229 with a Short Ratio of 9.88, compared to 1728950400 on 9591716. Therefore, it implies a Short% of Shares Outstanding of 7225229 and a Short% of Float of 23.74.

Most Popular